We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04416984
Brief Title: Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma (ALPHA2) (ALPHA2)

First Submitted : May 29, 2020
First Submitted that Met QC Criteria : June 2, 2020
First Posted : June 4, 2020

Last Update Submitted that Met QC Criteria : March 31, 2022
Last Update Posted : April 8, 2022